Replies to post #3211 on Palatin Technologies Inc. (PTN)

[goodfela58]

I agree too that an injection is not optimal. That said, there is really no reason this should stay down. They have $60 million more than they had last week and an FDA approval that they stand to make another $300 million in milestone sales of the drug. They don’t have to pay any marketing costs. It’s just all profit and potential profit.

The stock was trading higher last week with none if this.